Cardium Therapeutics (CXM)

0.38 +0.00  +1.02%  Feb 03, 11:00PM Go Pro
Watch
View Full Chart CXM Price Chart

Key Stats

Market Cap 31.17M
Revenue Growth
Profit Margin
Earnings Yield -13.33%
Dividend Yield 0.00%
Earnings Per Share TTM -0.05
PE Ratio
Price / Sales Ratio
52 Week High 0.59
52 Week Low 0.13
Beta 2.60
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

Profile

Exchange: AMEX       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cardium Therapeutics is down N/A over the last year vs S&P 500 Total Return up N/A, Reliv' International down N/A, and Insmed down N/A.

  • CXM Total Returns
  • ^SPXTR Total Returns
  • RELV Total Returns
  • INSM Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring CXM

Did Cardium Therapeutics make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

CXM Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
CXM 0.38 0.00 1.02% 31.17M
TNA 63.13 4.00 6.77%
IHF 62.85 0.17 0.27%
SKF 46.76 -2.36 -4.80%
AFK 29.24 0.46 1.58%
VE 12.46 0.34 2.81% 6.22B
RIMM 16.88 -0.33 -1.92% 8.85B
BCS 15.10 0.68 4.72% 47.58B
WFC 30.63 0.73 2.44% 161.53B
SRS 30.58 -0.96 -3.04%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close